Literature DB >> 19820945

High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds.

Siddharth Tiwari1, Devesh K Mishra, Sribash Roy, Ankit Singh, P K Singh, Rakesh Tuli.   

Abstract

A synthetic DNA construct containing cholera toxin B subunit, genetically fused to the surface glycoprotein of rabies virus was expressed in tobacco plants from a seed specific (legumin) promoter. Seed specific expression was monitored by real-time PCR, GM1-ELISA and Western blot analyses. The fusion protein accumulated in tobacco seeds at up to 1.22% of the total seed protein. It was functionally active in binding to the GM1-ganglioside receptors, suggesting its assembly into pentamers in seeds of the transgenic plants. Immunoblot analysis confirmed that the approximately 80.6 kDa monomeric fusion polypeptide was expressed in tobacco seeds and accumulated as an approximately 403 kDa pentamer. Evaluation of its immunoprotective ability against rabies and cholera is to be examined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820945     DOI: 10.1007/s00299-009-0782-3

Source DB:  PubMed          Journal:  Plant Cell Rep        ISSN: 0721-7714            Impact factor:   4.570


  54 in total

1.  The effect of T-DNA copy number, position and methylation on reporter gene expression in tobacco transformants.

Authors:  S L Hobbs; P Kpodar; C M DeLong
Journal:  Plant Mol Biol       Date:  1990-12       Impact factor: 4.076

2.  Mucosal immunization using recombinant plant-based oral vaccines.

Authors:  Stephen J Streatfield
Journal:  Methods       Date:  2006-02       Impact factor: 3.608

3.  The binding potential between the cholera toxin B-oligomer and its receptor.

Authors:  Xian-E Cai; Jie Yang
Journal:  Biochemistry       Date:  2003-04-15       Impact factor: 3.162

4.  Sequences responsible for the tissue specific promoter activity of a pea legumin gene in tobacco.

Authors:  A Shirsat; N Wilford; R Croy; D Boulter
Journal:  Mol Gen Genet       Date:  1989-01

5.  Gangliosides and membrane receptors for cholera toxin.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

6.  Rabies ribonucleocapsid as an oral immunogen and immunological enhancer.

Authors:  D C Hooper; I Pierard; A Modelska; L Otvos; Z F Fu; H Koprowski; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

7.  M13 bacteriophage vectors for the expression of foreign proteins in Escherichia coli: the rabies glycoprotein.

Authors:  R F Lathe; M P Kieny; D Schmitt; P Curtis; J P Lecocq
Journal:  J Mol Appl Genet       Date:  1984

Review 8.  Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Authors:  H Daniell; S J Streatfield; K Wycoff
Journal:  Trends Plant Sci       Date:  2001-05       Impact factor: 18.313

9.  Delivery of subunit vaccines in maize seed.

Authors:  Barry J Lamphear; Stephen J Streatfield; Joseph M Jilka; Christopher A Brooks; Donna K Barker; Debra D Turner; Donna E Delaney; Martin Garcia; Barry Wiggins; Susan L Woodard; Elizabeth E Hood; Ian R Tizard; Bruce Lawhorn; John A Howard
Journal:  J Control Release       Date:  2002-12-13       Impact factor: 9.776

10.  Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

Authors:  H S Mason; T A Haq; J D Clements; C J Arntzen
Journal:  Vaccine       Date:  1998-08       Impact factor: 3.641

View more
  4 in total

1.  Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination for rabies.

Authors:  Ankit Singh; Subhi Srivastava; Ankita Chouksey; Bhupendra Singh Panwar; Praveen C Verma; Sribash Roy; Pradhyumna K Singh; Gauri Saxena; Rakesh Tuli
Journal:  Mol Biotechnol       Date:  2015-04       Impact factor: 2.695

2.  Expression and subcellular targeting of human complement factor C5a in Nicotiana species.

Authors:  Henrik Nausch; Heike Mikschofsky; Heike Mischofsky; Roswitha Koslowski; Udo Meyer; Inge Broer; Jana Huckauf
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 3.  Recombinant Plant Engineering for Immunotherapeutic Production.

Authors:  Ankit Singh; Gurminder Kaur; Sanchita Singh; Neetu Singh; Gauri Saxena; Praveen C Verma
Journal:  Curr Mol Biol Rep       Date:  2017-10-16

Review 4.  Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa.

Authors:  Pingdwende Kader Aziz Bamogo; Christophe Brugidou; Drissa Sérémé; Fidèle Tiendrébéogo; Florencia Wendkuuni Djigma; Jacques Simpore; Séverine Lacombe
Journal:  Virol J       Date:  2019-12-30       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.